Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ANTHERA PHARMACEUTICALS INC

End-of-day quote Nasdaq  -  07:39 2022-10-06 pm EDT
- USD    0.00%
2018Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index
CI
2018Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index
CI
2018Anthera Pharmaceuticals, Inc. Reports Top Line Data from the Result Phase 3 Clinical Study of Sollpura
CI
 SummaryNewsCompanyFunds 
Company
Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. The Company has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement... 
More about the company
All news about ANTHERA PHARMACEUTICALS INC
2018Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped fr..
CI
2018Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped fr..
CI
2018Anthera Pharmaceuticals, Inc. Reports Top Line Data from the Result Phase 3 Clinical St..
CI
2018Transcript : Anthera Pharmaceuticals, Inc. - Special Call
CI
2018Anthera Mulls Acquisitions
CI
2018Anthera Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the..
CI
2018Anthera Pharmaceuticals, Inc. Concludes Last Patient Visit in the Phase 3 Result Clinic..
CI
2018Anthera Pharmaceuticals, Inc. announced that it has received $15 million in funding fro..
CI
2018Anthera Pharmaceuticals, Inc. Appoints Patrick Murphy as Senior Vice President, Manufac..
CI
2017Anthera Pharmaceuticals, Inc. Announces Positive Outcome of Interim Futility Analysis i..
CI
2017Anthera Pharmaceuticals Announces Completion of Recruitment in the Phase 3 RESULT Clini..
CI
2017Anthera Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the T..
CI
2017Anthera Pharmaceuticals, Inc. announced that it expects to receive $15 million in fundi..
CI
2017Anthera Pharmaceuticals, Inc. Announces Top Line Final Data from Phase 2 BRIGHT-SC Stud..
CI
2017Anthera Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the S..
CI
More news
News in other languages on ANTHERA PHARMACEUTICALS INC
2016Wall Street termine dans le rouge, le rally s'essouffle
More news
Managers and Directors
David E. Thompson Independent Director
Brent Furse Independent Director
Bradley A. Bugdanowitz Secretary
Sector and Competitors
1st jan.Capi. (M$)
ANTHERA PHARMACEUTICALS INC0
REGENERON PHARMACEUTICALS, INC.18.08%79 719
VERTEX PHARMACEUTICALS37.53%77 456
BIONTECH SE-46.78%33 340
WUXI APPTEC CO., LTD.-39.54%29 208
GENMAB A/S1.14%22 982